All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

1,268

Reset

1,268 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • ALK201Phase 22 trials

    Shanghai Allink Biotherapeutics Co., Ltd. · NSCLC (Advanced Non-small Cell Lung Cancer), Advanced Cancer, Advanced Solid Tumors

  • Ametinib MesylatePhase 22 trials

    Shanghai Hengrui Pharmaceutical Co., Ltd. · Advanced Solid Tumors, Non-small Cell Lung Cancer (NSCLC)

  • and oxaliplatinPhase 22 trials

    Suzhou Suncadia Biopharmaceuticals Co., Ltd. · HER2 Expression Gastric Cancer/Gastroesophageal Junction Adenocarcinoma, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma

  • AST-3424Phase 22 trials

    Zhejiang Hisun Pharmaceutical Co. Ltd. · HCC - Hepatocellular Carcinoma, Advanced Solid Tumors, Hepatocellular Carcinoma

  • Shanghai Juncell Therapeutics · Non Small Cell Lung Cancer, Melanoma

  • AVZO-021Phase 22 trials

    Avenzo Therapeutics, Inc. · HR+/HER2- Breast Cancer, HR+, HER2-, Advanced Breast Cancer, Advanced Solid Tumor

  • AZD0171MSC-1Phase 22 trials

    AstraZeneca · Non-small Cell Lung Cancer, Locally Advanced or Metastatic Solid Tumours

  • AZD2287Imaging agentPhase 22 trials

    AstraZeneca · Metastatic Prostate Cancer

  • AZD3470Phase 22 trials

    AstraZeneca · Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma

  • AzeliragonPhase 22 trials

    Cantex Pharmaceuticals · Glioblastoma

  • B1962Phase 22 trials

    Tasly Biopharmaceuticals Co., Ltd. · Recurrent Platinum-resistant Epithelial Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Cervical Cancers

  • B7-H3 CAR-NKEB-G3B7-NK dual-target CAR-NK cells, Dual-target GPC3Phase 22 trials

    Beijing Biotech · Advanced Hepatocellular Carcinoma (HCC), Metastatic Liver Cancer, Relapsed Neuroblastoma

  • BelvarafenibHM95573Phase 22 trials

    Hanmi Pharmaceutical Company Limited · Advanced or Metastatic Melanoma, Solid Tumors

  • BEY1107Phase 22 trials

    BeyondBio Inc. · Metastatic Colorectal Cancer, Locally Advanced or Metastatic Pancreatic Cancer

  • BL-M09D1Phase 22 trials

    Sichuan Baili Pharmaceutical Co., Ltd. · Solid Tumors, Gynecological Malignancies, Urothelial Carcinoma (UC)

  • BLEX 404Phase 22 trials

    Rgene Corporation · Pancreatic Cancer, Nonsquamous Nonsmall Cell Neoplasm of Lung

  • BLEX 404 LiquidPhase 22 trials

    BioLite, Inc. · Myelodysplastic Syndrome (MDS), Triple Negative Breast Cancer

  • BNT326Phase 22 trials

    BioNTech SE · Advanced Solid Tumor, Non-small Cell Lung Cancer

  • BreakVaxPhase 22 trials

    BreakBio Corp · Triple-Negative Breast Cancer (TNBC), Glioblastoma (GBM)

  • BRIMOCHOL PF eye dropsCARBACHOL PF eye drops, Brimonidine tartrate eye dropsPhase 22 trials

    Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. · Presbyopia, Recurrent Ovarian Cancer, Folate Receptor-Alpha Positive

  • BT7480Phase 22 trials

    BicycleTx Limited · Advanced Solid Tumors, Advanced Solid Tumor

  • CAB-AXL-ADCBA3011Phase 22 trials

    BioAtla, Inc. · Non-Small-Cell Lung Cancer, Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma

  • CamonsertibRP-3500Phase 22 trials

    Roche (Genentech) · Solid Tumors, Advanced Solid Tumor

  • Carboplatin AUC-5Phase 22 trials

    Inhibrx Biosciences, Inc · Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer

  • Checkpoint InhibitorPhase 22 trials

    EpicentRx, Inc. · Solid Tumor, Adult, Cancer, Neoplasms

  • COH04S1GEO-CM04S1, Synthetic MVA-based SARS-CoV-2 Vaccine GEO-CM04S1Phase 22 trials

    GeoVax, Inc. · COVID-19 Infection, Hematopoietic and Lymphoid System Neoplasm, Leukemia

  • CVL006Phase 22 trials

    Convalife (Shanghai) Co., Ltd. · Advanced Solid Tumor

  • CVL237Phase 22 trials

    Convalife (Shanghai) Co., Ltd. · Advanced Solid Tumors, Locally Advanced or Metastatic Solid Tumors, PTEN Loss or Low Expression

  • CVM-1118TRX-818Phase 22 trials

    TaiRx, Inc. · Hepatocellular Carcinoma, Advanced Cancer, Neuroendocrine Tumors

  • CYH33Phase 22 trials

    Haihe Biopharma Co., Ltd. · PIK3CA-Related Overgrowth Spectrum (PROS), PIK3CA-related Vascular Malformations (PRVM), Ovarian Cancer

  • D3S-001Phase 22 trials

    D3 Bio (Wuxi) Co., Ltd · Advanced Solid Tumors With MAPK Pathway Mutations, KRAS P.G12C

  • DanburstotugIMC-001Phase 22 trials

    ImmuneOncia Therapeutics Inc. · TMB-H, Histologically or Cytologically Proven Metastatic or Locally Advanced Solid Tumors, Extranodal NK/T-cell Lymphoma, Nasal Type

  • DB-1305BNT325Phase 22 trials

    DualityBio Inc. · Solid Tumors, Advanced Solid Tumor

  • DenikitugGS-1811, DENPhase 22 trials

    Gilead Sciences · Advanced Microsatellite Stable Colorectal Cancer, HER2-negative, Gastroesophageal Junction

  • DNA VaccinePhase 22 trials

    NEC Bio B.V · Triple Negative Breast Cancer, Malignant Melanoma, Melanoma (Skin)

  • DOC1021Phase 22 trials

    Diakonos Oncology Corporation · Glioblastoma (GBM), Refractory Melanoma

  • Dositinib mesylatePhase 22 trials

    Henan Genuine Biotech Co., Ltd. · Non-Small Cell Lung Cancer

  • DS-3939aPhase 22 trials

    Daiichi Sankyo · Solid Tumor, Locally Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer

  • DS-8201Phase 22 trials

    Sichuan Baili Pharmaceutical Co., Ltd. · Breast Cancer, Advanced Solid Tumor

  • DS010Phase 22 trials

    Dartsbio Pharmaceuticals Ltd. · Cancer, Cachexia

  • DSP107Phase 22 trials

    Kahr Bio Australia Pty Ltd · Colorectal Cancer, Advanced Solid Tumor, Non Small Cell Lung Cancer

  • Beijing Biotech · Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Carcinoma

  • DZD6008Phase 22 trials

    Dizal Pharmaceuticals · Non-Small Cell Lung Cancer, Non Small Cell Lung Cancer

  • EB-DART-NK01DLL3, CD56 CAR-NK cellsPhase 22 trials

    Beijing Biotech · Small Cell Lung Cancer (SCLC), Relapsed/Refractory SCLC, Extensive-stage SCLC

  • EB-DNK101 dual-targeting CAR-NK cellsMSLN + MUC1Phase 22 trials

    Beijing Biotech · Pancreatic Ductal Adenocarcinoma (PDAC), Unresectable Locally Advanced or Metastatic Disease, Unresectable Locally Advanced

  • EB-DNK102 dual-targeting CAR-NK cellsCLDN18.2 + MUC1Phase 22 trials

    Beijing Biotech · Pancreatic Ductal Adenocarcinoma (PDAC), Unresectable Locally Advanced or Metastatic Disease, Unresectable Locally Advanced

  • EB-DUO-CAR-NK-CEAGCCPhase 22 trials

    Beijing Biotech · Colorectal Cancer Metastatic, Adenocarcinoma of Colon, Colorectal Cancer

  • endoxifenPhase 22 trials

    Atossa Therapeutics, Inc. · Precocious Puberty, Gonadotropin-dependent, Breast Neoplasms, Invasive Breast Cancer

  • ERAS-007Phase 22 trials

    Erasca, Inc. · Advanced or Metastatic Solid Tumors, Metastatic Colorectal Cancer, Metastatic Pancreatic Ductal Adenocarcinoma

  • FG-B901Phase 22 trials

    FutureGen Biopharmaceutical (Beijing) Co., Ltd · Claudin 18.2, Solid Tumor Malignancies, Solid Tumor

NewerPage 11 of 26Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.